Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Intrasense SAS

+ Add to Watchlist


1.6500 EUR 0.0100 0.60%

As of 10:52:41 ET on 02/27/2015.

Snapshot for Intrasense SAS (ALINS)

Open: 1.6600 Day's Range: 1.6300 - 1.6600 Volume: 7,928
Previous Close: 1.6600 52wk Range: 1.3800 - 5.0500 1-Yr Rtn: -66.73%

Stock Chart for ALINS

No chart data available.
  • ALINS:FP 1.6500
  • 1D
  • 1M
  • 1Y
Interactive ALINS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALINS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.8700
Est. PEG Ratio -
Market Cap (M EUR) 6.99
Shares Outstanding (M) 4.24
30 Day Average Volume 25,222
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALINS

No data available

Company Profile & Key Executives for ALINS

Intrasense SAS develops and markets computer software for the review and analysis of medical images. The software reconstruct interactive two and three dimensional images from CT-scans, magnetic resonance imaging or PET scan studies, and helps radiologists, surgeons and clinicians interpret images, decide and plan therapies, and quantify tumor response.

Stephane ChemounyChairman/Co-FounderPatrick MayetteCEO/Co-Founder
More Company Profile & Key Executives for ALINS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil